Asma Patel, VP at Quotient Sciences, addresses the biggest challenges in complex small molecule formulation development and provides a roadmap for keeping speed to clinic while reducing risk.
Solubility and Bioavailability
Early characterization and enabling technologies help overcome poor solubility and variable absorption before they derail a program.
Tech Transfer and Scale-Up
Planning for scale-up from the first formulation decision reduces rework and protects timelines.
Batch Consistency
Robust process understanding and analytical control deliver consistent batches from clinical through commercial supply.
About This White Paper
This white paper is published by Quotient Sciences and curated by Biotechnology Media Insights, a trusted source for pharmaceutical and biotechnology research, technical guides and industry analysis.